Health Canada is now reviewing the use of the Moderna COVID-19 vaccine for youth between 6 and 11 years old.
Health Canada says their assessment will include a detailed review of clinical trial results, as well as other evolving data and information about the health impacts of COVID-19 and variants of concern on children in Canada.
This is now the second submission Health Canada has received for the use of a COVID-19 vaccine in this age group, after Pfizer submitted for approval on October 18 – which is still under review.
Pediatric data on kids between five and 11 from early October showed a safe and strong immune response from two doses of a COVID-19 vaccine, which are one-third the size given to teens and adults.
The Northwestern Health Unit has said the expected timeline to when doses will be administered for kids will be around Christmas.